| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T173 |
0-34 |
Sentence |
denotes |
Clinical Trial Update on 2019-nCoV |
| T174 |
35-179 |
Sentence |
denotes |
A total of 233 trials are registered till date in the Chinese Clinical Trial Registry[94] (dated Feb 24, 2020, keywords 2019-nCov and COVID-19). |
| T175 |
180-519 |
Sentence |
denotes |
Among the pharmacotherapeutic agents evaluated, some of the highlighted agents, which are being evaluated, are high-dose Vitamin C, favipiravir, adalimumab, dihydro-artemisinin piperaquine, leflunomide, dipyridamole, chloroquine or hydroxychloroquine, suramin sodium, lopinavir/ritonavir and arbidol (umifenovir) tablets, and IFN-alpha 2b. |
| T176 |
520-693 |
Sentence |
denotes |
Other important agents being evaluated are Huo-Shen particles, Xiyanping injection, Shen-Fu injection, etc., many of which are from traditional Chinese medicines background. |
| T177 |
694-745 |
Sentence |
denotes |
Use of stem cells is also evaluated frequently.[94] |
